Dr. Austin Fontenot

What the Evidence Actually Says

The supplement industry generates over $50 billion annually in the United States alone. Yet for every well-studied compound with replicable clinical data, there are dozens of products marketed on mechanistic plausibility, cherry-picked studies, or outright fiction. This page cuts through that noise.

What follows is an evidence-based review of the supplements most commonly used for pain, joint health, and musculoskeletal recovery. Each is evaluated on the quality and consistency of its clinical evidence—not on marketing claims. Ratings reflect the current weight of peer-reviewed literature, not manufacturer-funded studies alone.

Omega-3 Fatty Acids (Fish Oil)

Evidence Rating: Strong ✓✓✓

Omega-3 fatty acids — primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — are among the most extensively studied supplements in musculoskeletal and pain medicine. Their anti-inflammatory mechanism is well characterized: EPA and DHA compete with arachidonic acid for COX and LOX enzymes, shifting eicosanoid production toward less inflammatory prostaglandins and leukotrienes, and serving as precursors to specialized pro-resolving mediators (SPMs) including resolvins, protectins, and maresins.¹

Joint Pain and Rheumatoid Arthritis

The clinical evidence for omega-3s in joint pain is robust. A 2012 meta-analysis of 17 RCTs found that omega-3 supplementation significantly reduced patient-reported joint pain intensity, morning stiffness, and NSAID consumption in rheumatoid arthritis patients.² A 2018 Cochrane review confirmed benefit for RA joint symptoms. Standard dosing in trials: 2–4g combined EPA+DHA daily.

Osteoarthritis

Evidence in OA is more modest but emerging. A 2016 RCT in 202 patients with hip or knee OA found that high-dose fish oil (4.5g/day) reduced pain scores and improved function compared to low-dose, though effect sizes were modest. (Lim WS et al. A randomized, double-blind, placebo-controlled trial of fish oil in osteoarthritis. Ann Rheum Dis. 2016;75:23–32.) Mechanistically, omega-3s may slow cartilage degradation by downregulating MMP-3 and MMP-13 expression.

Post-Exercise Recovery

Omega-3 supplementation (2–3g EPA+DHA/day for ≥4 weeks) attenuates delayed onset muscle soreness (DOMS) and reduces markers of exercise-induced inflammation (CRP, IL-6) in multiple RCTs. It also potentiates muscle protein synthesis when combined with adequate protein, particularly in older adults. (Smith GI et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults. Am J Clin Nutr. 2011;93(2):402–412.)

Bottom line: One of the most evidence-backed supplements on this list. A daily dose of 2–4g EPA+DHA is reasonable for most adults with joint pain or active recovery goals. Choose triglyceride-form fish oil for superior absorption. Algae-based EPA/DHA is a clinically equivalent vegan alternative.

Glucosamine & Chondroitin

Evidence Rating: Moderate (context-dependent) ✓✓

Glucosamine and chondroitin are naturally occurring compounds in cartilage. Glucosamine is an amino sugar that serves as a substrate for glycosaminoglycan synthesis; chondroitin sulfate is a sulfated glycosaminoglycan that provides compressive resistance to cartilage. They are almost always studied and sold together, though some trials isolate each compound.

What the Trials Show

The landmark GAIT trial (Glucosamine/chondroitin Arthritis Intervention Trial), funded by the NIH and involving 1,583 knee OA patients, found that the combination did not outperform placebo for mild knee pain overall — but in the subgroup with moderate-to-severe pain, the combination produced a statistically significant response (79.2% vs. 54.3% for placebo).³ Subsequent meta-analyses have produced mixed results, with effect sizes generally small to modest.

Structural vs. Symptomatic Effects

Some trials suggest chondroitin sulfate may slow joint space narrowing in knee OA — a structural benefit beyond pain relief. Clinical guidelines have recognized glucosamine and chondroitin as conditionally recommended options for knee OA management.⁴ The key caveat: pharmaceutical-grade chondroitin differs substantially from most retail supplement formulations in purity and bioavailability.

The Hype Problem

Consumer-grade glucosamine and chondroitin products vary widely in actual content — independent testing has found some products contain as little as 10% of the labeled dose. This quality gap may explain the inconsistency between clinical trials using pharmaceutical-grade compounds and real-world outcomes. (Consumerlab.com supplement quality reports, 2023.)

Bottom line: Worth a trial (3–6 months) for moderate-to-severe knee OA, particularly if NSAIDs are being used or poorly tolerated. Use pharmaceutical-grade chondroitin when possible. Evidence is weakest for mild OA and essentially absent for non-knee joints. Not a rescue therapy — effects, when present, develop slowly.

Curcumin (Turmeric)

Evidence Rating: Moderate ✓✓ (with bioavailability caveats)

Curcumin is the primary bioactive polyphenol in turmeric (Curcuma longa). It inhibits NF-κB signaling, suppresses COX-2 and 5-LOX enzyme activity, and downregulates pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. On paper, the mechanism is compelling. The clinical reality is more complicated — largely because standard curcumin has notoriously poor oral bioavailability, with less than 1% absorbed intact from the GI tract. (Anand P et al. Bioavailability of curcumin: problems and promises. Mol Pharmaceutics. 2007;4(6):807–818.)

Joint Pain and OA Evidence

Multiple RCTs have found curcumin comparable to NSAIDs (ibuprofen, diclofenac) for knee OA pain and function when using enhanced-bioavailability formulations. A 2021 non-inferiority trial found bioavailable turmeric extract comparable to paracetamol for knee OA pain reduction over 12 weeks.⁵ A 2016 systematic review and meta-analysis of randomized clinical trials ranked curcumin extracts among the top interventions for joint arthritis symptom relief.⁶

The Bioavailability Problem

Standard turmeric powder and most capsules deliver negligible curcumin to circulation. Bioavailability-enhanced forms with meaningful clinical evidence include: Meriva (phytosome/phosphatidylcholine complex), Theracurmin (colloidal nanoparticle dispersion), BCM-95/Biocurcumax (turmeric essential oil complex), and CurcuWIN (water-dispersible). Piperine (black pepper extract, BioPerine) increases absorption by ~2,000% and is inexpensive, though it can interfere with drug metabolism via CYP3A4 inhibition. (Shoba G et al. Influence of piperine on the pharmacokinetics of curcumin. Planta Med. 1998;64(4):353–356.)

Post-Surgical and Injury Recovery

A 2014 RCT of 40 patients undergoing laparoscopic cholecystectomy found curcumin (500mg TID) significantly reduced postoperative pain and fatigue at 2 weeks. Smaller studies suggest benefit in DOMS attenuation and soft tissue recovery, though effect sizes are modest. (Agarwal KA et al. Efficacy of turmeric in relieving post-operative inflammation. Indian J Physiol Pharmacol. 2011;55(1):60–70.)

Bottom line: Promising for OA joint pain with effect sizes comparable to low-dose NSAIDs — but only with bioavailability-enhanced formulations. Buying cheap turmeric capsules is largely a waste of money. Look for Meriva, Theracurmin, BCM-95, or a piperine-combined product. Typical effective doses: 500–1,000mg curcuminoids daily in divided doses. Use with caution in patients on anticoagulants or CYP3A4-metabolized drugs.

Magnesium

Evidence Rating: Strong for deficiency-related pain ✓✓✓ | Moderate for performance recovery ✓✓

Magnesium is the fourth most abundant mineral in the body and a cofactor in over 300 enzymatic reactions, including ATP synthesis, protein synthesis, muscle contraction, and nerve signal transmission. An estimated 48% of Americans consume less than the recommended daily amount, making it one of the most clinically relevant micronutrient insufficiencies in musculoskeletal medicine. (Rosanoff A et al. Suboptimal magnesium status in the United States. Nutr Rev. 2012;70(3):153–164.)

Muscle Pain and Cramping

Low serum magnesium is strongly associated with muscle cramps, spasms, and myofascial pain — a relationship well-documented in the clinical literature.⁷ A systematic review found that magnesium supplementation significantly reduced nocturnal leg cramps in adults, though effect sizes were modest and evidence quality varied. Athletes in heavy training are at particular risk for magnesium depletion due to increased urinary and sweat losses — deficiency impairs neuromuscular function and increases susceptibility to exercise-induced muscle damage.

Chronic Pain and Central Sensitization

Magnesium is an endogenous antagonist of the NMDA receptor, which plays a central role in pain wind-up and central sensitization. Magnesium deficiency removes this blockade, lowering the pain threshold and amplifying nociceptive signaling. Intravenous magnesium has been used perioperatively to reduce opioid requirements and postoperative pain, and oral magnesium has shown benefit in fibromyalgia and chronic low back pain in small trials. (Yousef AA, Al-deeb AE. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain. Anaesthesia. 2013;68(3):260–266.)

Sleep and Recovery

Magnesium plays a critical role in sleep architecture — it facilitates GABA receptor activity and regulates melatonin. Evidence also supports its role in reducing subjective anxiety and stress, which can significantly impair recovery quality.⁸ A 2012 RCT of 46 older adults with insomnia found that 500mg/day magnesium significantly improved sleep time, sleep efficiency, and early morning awakening compared to placebo. Improved sleep directly supports musculoskeletal recovery through GH secretion and tissue repair.

Forms and Dosing

Not all magnesium forms are equivalent. Magnesium oxide (the most common retail form) has ~4% absorption and is largely useless beyond laxative effects. Superior forms: Magnesium glycinate (highly absorbable, gentle on GI, best for sleep/pain), Magnesium malate (well-tolerated, preferred for fibromyalgia/fatigue), Magnesium threonate (crosses the blood-brain barrier, studied for cognitive effects), Magnesium citrate (good absorption, mild laxative effect at higher doses). Typical therapeutic dose: 200–400mg elemental magnesium daily in divided doses.

Bottom line: Correct a deficiency first — most people are below optimal. For musculoskeletal pain, cramping, poor sleep, or active training load, magnesium glycinate or malate at 200–400mg/day is low-risk, low-cost, and broadly beneficial. Avoid oxide forms.

Creatine Monohydrate

Evidence Rating: Strong ✓✓✓

Creatine is the most studied performance supplement in existence, with over 500 peer-reviewed studies spanning four decades. It is not just a gym supplement — its applications in musculoskeletal recovery, post-surgical rehabilitation, sarcopenia prevention, and even neurological protection are increasingly recognized in clinical literature.⁹ Endogenously synthesized in the liver and kidneys from arginine and glycine, creatine is stored primarily in skeletal muscle as phosphocreatine, where it serves as a rapid ATP buffer during high-intensity effort.

Muscle Mass and Strength in Recovery

Creatine supplementation during immobilization (post-surgery, casting, bed rest) significantly attenuates muscle atrophy and strength loss. A 2001 RCT found that creatine supplementation during 2 weeks of arm immobilization followed by rehabilitation resulted in significantly greater muscle mass and strength recovery compared to placebo. (Hespel P et al. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol. 2001;536(2):625–633.) This is clinically meaningful for post-operative orthopedic patients.

Older Adults and Sarcopenia

Creatine’s evidence base in older adults is robust. A meta-analysis found that creatine supplementation combined with resistance training significantly increased lean mass and upper and lower body strength in adults over 55 compared to training alone.¹⁰ Given sarcopenia’s role in frailty, fall risk, and orthopedic outcomes, this is high-value territory.

Bone Health

Emerging evidence suggests creatine may support bone metabolism by upregulating osteogenic markers. A 2014 RCT found that creatine + resistance training significantly improved hip bone mineral density in older men compared to placebo + training. (Chilibeck PD et al. Effect of creatine supplementation during resistance training on bone mineral density in older males. J Nutr Health Aging. 2005;9(5):352–353.) The mechanism may involve increased IGF-1 signaling and mechanical loading benefits from greater training capacity.

Dosing

Loading protocol (faster saturation): 20g/day in 4 divided doses for 5–7 days, then 3–5g/day maintenance. Maintenance-only protocol: 3–5g/day — achieves full saturation in ~28 days. No meaningful difference in long-term outcomes between protocols. Creatine monohydrate is the gold standard — no proprietary form (Kre-Alkalyn, buffered, ethyl ester) has outperformed it in head-to-head trials. Take with carbohydrates to enhance muscle uptake. Non-responders (~25–30% of people) tend to have naturally higher baseline creatine stores.

Bottom line: Creatine monohydrate belongs in the toolkit of any patient undergoing orthopedic rehabilitation, any older adult doing resistance training, and any athlete optimizing recovery. It is safe, inexpensive, and the evidence is unambiguous. The old kidney-damage concern has been thoroughly debunked in healthy individuals at standard doses.

Collagen Peptides

Evidence Rating: Moderate ✓✓ (emerging, promising)

Hydrolyzed collagen (collagen peptides) has gained significant research traction over the past decade as a targeted intervention for cartilage, tendon, and bone health. Unlike generic protein supplements, hydrolyzed collagen delivers specific dipeptides — particularly prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly) — that have been shown in cell studies to stimulate chondrocyte and fibroblast collagen synthesis directly. (Shigemura Y et al. Identification of HPGG and GPAG as collagen-derived peptides with specific bioactivity. J Agric Food Chem. 2009.)

Joint and Cartilage Evidence

A 24-week RCT of 147 athletes at Penn State University found that collagen hydrolysate (10g/day) significantly reduced joint pain during activity compared to placebo, with the largest effects in athletes who had the most pain at baseline.¹¹ A 2021 systematic review of 15 RCTs concluded that collagen supplementation significantly improved joint pain and function in OA patients.

Tendon and Ligament Repair

A landmark 2017 RCT by Shaw et al. found that 15g of gelatin (a whole-food collagen source) taken with 48mg vitamin C 1 hour before intermittent exercise doubled circulating amino terminal propeptide of collagen type I (PINP) — a marker of collagen synthesis — and increased the mechanical properties of engineered ligaments in vitro.¹¹ Timing and vitamin C co-administration appear critical; collagen synthesis requires vitamin C as a cofactor for hydroxylation of proline and lysine residues.

Bone Health

A 2018 RCT of 102 postmenopausal women found that specific collagen peptides (5g/day for 12 months) significantly increased bone mineral density at the spine and femoral neck compared to placebo, with concurrent increases in bone formation markers and decreases in bone resorption markers. (König D et al. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women. Nutrients. 2018;10(1):97.)

Bottom line: One of the more compelling emerging supplements for active individuals and those recovering from tendon, ligament, or cartilage injuries. Take 10–15g collagen peptides with 50mg+ vitamin C, 30–60 minutes before exercise or physical therapy. Timing matters — the collagen peptides need to circulate when the tissue is being mechanically loaded. Type II collagen (undenatured, UC-II) at lower doses (40mg/day) shows separate evidence for OA specifically.

Supplements with Weak or Overhyped Evidence

Not every supplement that sells well has the evidence to back it up. The following compounds are commonly marketed for pain, joint health, or recovery — but their clinical evidence is limited, inconsistent, or significantly weaker than their marketing implies.

Boswellia Serrata

Evidence Rating: Moderate ✓✓ (promising but limited trial quality). Boswellia contains boswellic acids that inhibit 5-LOX, reducing leukotriene production. Several small RCTs show modest benefit for knee OA pain. A 2019 Cochrane review found low-certainty evidence of small improvements in pain and function. Trials are generally short, underpowered, and industry-funded. Worth a trial for OA patients who cannot tolerate NSAIDs, but don’t expect dramatic results. (Bannuru RR et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis. Osteoarthritis Cartilage. 2009.)

MSM (Methylsulfonylmethane)

Evidence Rating: Weak ✓ (insufficient evidence). MSM is a sulfur-containing compound marketed for joint pain and inflammation. A handful of small RCTs show modest short-term reductions in OA pain, but trials are poorly designed, underpowered, and lack long-term data. The mechanism by which it might work is unclear. The evidence does not yet justify strong clinical recommendations — though it appears safe. (Butawan M et al. Methylsulfonylmethane: applications and safety of a novel dietary supplement. Nutrients. 2017;9(3):290.)

Hyaluronic Acid (Oral)

Evidence Rating: Weak to Moderate ✓ (oral form; injectable is separate). Intra-articular hyaluronic acid injections have a different (and better) evidence base. Oral hyaluronic acid has shown mixed results — some RCTs suggest modest improvement in knee OA symptoms, but bioavailability questions remain and effect sizes are small. Do not conflate the oral supplement with the injectable treatment. (Tashiro T et al. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis. Nutrition J. 2012;11:17.)

Arnica

Evidence Rating: Weak ✓ (topical only; oral is potentially unsafe). Topical arnica gel has limited evidence for mild OA pain and bruising. A small RCT found it comparable to ibuprofen gel for hand OA. Oral arnica (homeopathic or herbal) lacks meaningful evidence and the herb in high doses is toxic. Use only topical preparations. (Widrig R et al. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis. Rheumatol Int. 2007;27(6):585–591.)

CBD (Cannabidiol)

Evidence Rating: Insufficient human trial data ✗ (preclinical only for musculoskeletal use). CBD has robust preclinical anti-inflammatory and analgesic data in animal models. Human RCTs for musculoskeletal pain specifically are nearly absent as of 2024 — most human evidence is in neuropathic pain and epilepsy. Despite enormous consumer uptake, the clinical evidence base for OA, joint pain, and recovery in humans remains thin. This may change as trials complete. Product quality is also a major concern — independent testing consistently finds mislabeled CBD content. (Vučković S et al. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259.)

Collagen Type II (UC-II)

Evidence Rating: Moderate ✓✓ (distinct from collagen peptides). Undenatured type II collagen (UC-II) works via a different mechanism than hydrolyzed collagen peptides — oral tolerance induction in gut-associated lymphoid tissue, reducing immune reactivity to cartilage collagen. At a low dose of 40mg/day, several RCTs show meaningful reductions in OA knee pain, with one head-to-head trial outperforming glucosamine + chondroitin. Worth noting separately from hydrolyzed collagen, as the mechanism and dose are entirely different. (Crowley DC et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee. Int J Med Sci. 2009;6(6):312–321.)

Vitamin D

Evidence Rating: Strong for deficiency correction ✓✓✓ | Moderate for pain reduction ✓✓

Vitamin D is technically a prohormone, not a vitamin. Its active form — 1,25-dihydroxyvitamin D (calcitriol) — binds to vitamin D receptors (VDR) present in skeletal muscle, immune cells, chondrocytes, and neurons, exerting broad effects on musculoskeletal function, immune regulation, and pain processing.¹² Globally, an estimated 1 billion people are vitamin D deficient. In the US, roughly 42% of adults have insufficient levels (<20 ng/mL).

Musculoskeletal Pain

The relationship between vitamin D deficiency and musculoskeletal pain is well-established. A 2008 systematic review found that vitamin D deficiency was significantly associated with chronic widespread pain and that correction of deficiency improved pain symptoms. (Plotnikoff GA, Quigley JM. Prev Med. 2003;37(5):432–439.) A 2016 meta-analysis of 22 RCTs found that vitamin D supplementation significantly reduced chronic pain scores, particularly in patients who were deficient at baseline. (Wu Z et al. Vitamin D supplementation and chronic pain: a meta-analysis. Pain Physician. 2016.)

Muscle Function and Injury Risk

Vitamin D deficiency is associated with proximal muscle weakness, poor balance, and increased fall risk — all critical in orthopedic recovery. Multiple trials show that supplementation improves muscle strength and physical performance in deficient individuals. In athletes, low vitamin D is associated with increased risk of stress fractures and muscle injuries. (Larson-Meyer DE, Willis KS. Vitamin D and athletes. Curr Sports Med Rep. 2010;9(4):220–226.)

Bone Health and Fracture Healing

Vitamin D is essential for calcium absorption and bone mineralization. Deficiency impairs fracture healing and is associated with delayed union. A 2020 meta-analysis found that combined vitamin D and calcium supplementation significantly reduced fracture risk in older adults. (Weaver CM et al. Calcium plus vitamin D supplementation and risk of fractures. Osteoporos Int. 2016;27(1):367–376.) Optimal serum level for musculoskeletal health: 40–60 ng/mL (100–150 nmol/L) — above the deficiency threshold but not supraphysiologic.

Dosing

Check serum 25(OH)D before supplementing — dosing should be guided by baseline levels. General population maintenance: 1,500–2,000 IU/day. Deficiency repletion: 4,000–6,000 IU/day for 8–12 weeks under clinical supervision. Take with the largest meal of the day (fat-soluble vitamin — absorption increases with dietary fat). Co-administer with vitamin K2 (MK-7, 100–200mcg/day) to support calcium routing to bone rather than soft tissue. (Kidd PM. Vitamins D and K as pleiotropic nutrients. Altern Med Rev. 2010;15(3):199–222.)

Bottom line: Get your levels tested. If you’re deficient, correcting it is one of the highest-yield, lowest-risk interventions in musculoskeletal medicine. The evidence for supplementing above 40 ng/mL for additional pain benefit is weaker — treat to target, not to a dose.

How to Build a Smart Supplement Stack

The mistake most people make is treating supplements as a substitute for the fundamentals. No supplement will outperform adequate protein intake, consistent resistance training, quality sleep, and a diet built around whole foods. Supplements are precisely that — supplemental. The hierarchy matters.

An Evidence-Based Starting Point

Tier 1 — High confidence, broad applicability:
• Vitamin D (if deficient — get tested)
• Magnesium glycinate (200–400mg/day — most people are low)
• Omega-3s (2–4g EPA+DHA/day — triglyceride form)
• Creatine monohydrate (3–5g/day — especially if 50+, post-surgical, or in active rehab)

Tier 2 — Condition-specific, meaningful evidence:
• Collagen peptides + vitamin C (10–15g pre-exercise or PT — tendon/ligament/cartilage injuries)
• Curcumin (500–1,000mg/day enhanced form — OA or chronic inflammatory pain)
• Glucosamine/Chondroitin (pharmaceutical grade — moderate-to-severe knee OA only)

Tier 3 — Emerging or context-dependent:
• Boswellia (OA, NSAID intolerance)
• UC-II collagen (40mg/day — knee OA specifically)
• Magnesium threonate (cognitive/sleep focus)

Quality Matters More Than Brand

The supplement industry is largely unregulated. Look for products with third-party testing certifications: NSF Certified for Sport, Informed Sport, USP Verified, or ConsumerLab approved. These programs independently verify that what is on the label is in the bottle — and that it is free of banned substances and contaminants. A $12 fish oil that tests at 40% of labeled EPA/DHA is not a bargain. A $45 certified product that delivers what it claims is.

Work With Your Provider

Some supplements interact with medications — curcumin and fish oil with anticoagulants, magnesium with certain antibiotics and diuretics, vitamin D with some cardiac medications. Others can mask symptoms or confound lab values. Before building a supplement regimen, discuss it with your physician or a registered dietitian with sports or clinical nutrition training. The goal is a stack that works with your treatment, not around it.

This page is updated as new evidence emerges. Evidence ratings reflect the state of the literature as of 2024–2025. Always cross-reference with current clinical guidelines and your own provider’s recommendations.